| Literature DB >> 31783854 |
Ermengol Coma1, Manuel Medina2, Leonardo Méndez2, Eduardo Hermosilla3, Manuel Iglesias4, Carmen Olmos4, Sebastian Calero5.
Abstract
BACKGROUND: Numerous studies have analyzed the effectiveness of electronic reminder interventions to improve different clinical conditions, and most have reported a small to moderate effect. Few studies, however, have analyzed reminder systems targeting multiple conditions, and fewer still have compared electronic point-of-care reminders systems with other forms of feedback designed to improve delivery of care.Entities:
Keywords: Electronic health record; Primary health care; Quality of health care; Reminder systems
Mesh:
Year: 2019 PMID: 31783854 PMCID: PMC6884876 DOI: 10.1186/s12911-019-0976-8
Source DB: PubMed Journal: BMC Med Inform Decis Mak ISSN: 1472-6947 Impact factor: 2.796
Clinical recommendations, conditions and type of reminder
| Recommendation | Clinical condition | Type of reminder |
|---|---|---|
| Moderately important (orange icon) | ||
| Measure blood pressure: ≤140/90 or ≤ 150/95 depending on risk status | High blood pressure/high cardiovascular risk | Measurement |
| Measure glycated hemoglobin: HbA1c ≤8% | Type 2 diabetes mellitus | Measurement |
| Measure cholesterol: LDL <120 | Cerebrovascular accident/ischemic heart disease | Measurement |
| Screen for diabetic retinopathy | Type 2 diabetes mellitus | Screening |
| Encourage smoking cessation | Smoking | Lifestyle |
| Provide Hepatitis B vaccination to patients with Hepatitis C | Hepatitis C | Vaccination |
| Very important (red icon) | ||
| Treat with ACEI/ARB | Heart failure | Treatment |
| Treat with beta blockers | Heart failure/ischemic heart disease | Treatment |
| Treat with antiplatelet drug/anticoagulant | Atrial fibrillation | Treatment |
| Treat with antiplatelet drug | Cerebrovascular accident/ischemic heart disease | Treatment |
Abbreviations: ACEI Angiotensin-converting enzyme inhibitor, ARB Angiotensin II receptor blocker, LDL Low-density lipoprotein
Fig. 1Screenshot of feedback screen that can be accessed by primary health care professionals within the centralized electronic medical records system. Well-established feedback without reminders (control group)
Differences between well-established feedback and electronic reminders
| Established feedback | Reminders | |
|---|---|---|
| Periodicity | Monthly | Weekly |
| Trigger | Professional initiative | Clinical encounter |
| What | 61 recommendations | 10 recommendations |
| When | Off-line | Online |
| Where | Web report | Reminder at the point-of-care |
| Configurability | No | Yes (in one subgroup) |
| Integration with electronic health record functionality | Low | High |
Fig. 2Workflow of study population
Baseline characteristics of primary care centers and patients with reminders in the control and intervention groups
| Control group | Intervention group | ||
|---|---|---|---|
| Patients with reminders | 317,117 | 328,728 | |
| Mean age | 66.38 | 66.48 | 0.0047 |
| 95% CI | (66.33–66.43) | (66.43–66.53) | |
| % women | 46.15 | 46.29 | 0.235 |
| Mean no. of reminders | 1.48 | 1.49 | 0.0012 |
| 95% CI | (1.47–1.48) | (1.48–1.49) | |
| Mean no. of visits per patient | 1.69 | 1.75 | 0.0000 |
| 95% CI | (1.68–1.70) | (1.74–1.75) | |
| Number of primary care centers | 137 | 132 | |
| % rural centers | 36.5 | 46.2 | 0.11 |
| % of teaching centers | 21.9 | 25.76 | 0.477 |
| Mean no. of patients >14 assigned | 16,279.81 | 17,429.42 | 0.2377 |
| 95% CI | (14,920.39–17,639.23) | (16,072.79–18,786.04) | |
| % population served | 70.7 | 71.23 | 0.4716 |
| 95% CI | (69.69–71.74) | (70.26–72.19) | |
| Mean no. of patients per general practitioner | 1337.21 | 1373.31 | 0.2565 |
| 95% CI | (1296.99–1377.43) | (1324.85–1421.77) | |
| Frequency of visits per patient per year | 6.85 | 6.99 | 0.4669 |
| 95% CI | (6.59–7.11) | (6.72–7.27) | |
| Mean no. of general practitioners per center | 11.97 | 12.52 | 0.3943 |
| 95% CI | (11.05–12.89) | (11.65–13.39) | |
| Mean no. of nurses per center | 12.73 | 13.18 | 0.4899 |
| 95% CI | (11.78–13.67) | (12.27–14.1) |
Fig. 3Percentage of reminders by clinical recommendation. Subtitle: Almost half of the reminders were to measure blood pressure. Abbreviations for Fig. 3: LDL: low-density lipids; HF: heart failure; IHD: ischemic heart disease; CVA: Cerebrovascular accident; ACEI: angiotensin-converting enzyme inhibitor; ARB: angiotensin II receptor blocker; AF: atrial fibrillation
Distribution of reminders by clinical condition and specific reminder in the intervention and control groups
| Control group reminders | Intervention group reminders | Total reminders | |||||
|---|---|---|---|---|---|---|---|
| Clinical condition | Type of reminder | No. | % | No. | % | No. | % |
| Type 2 diabetes mellitus | Screen for diabetic retinopathy | 34,748 | 7.4 | 36,649 | 7.5 | 71,397 | 7.45 |
| Measure glycated hemoglobin | 47,582 | 10.13 | 49,873 | 10.2 | 97,455 | 10.17 | |
| High blood pressure | Measure blood pressure | 22,0382 | 46.94 | 23,0559 | 47.17 | 45,0941 | 47.05 |
| Atrial fibrillation | Treat with antiplatelet drug/anticoagulant | 4650 | 0.99 | 4852 | 0.99 | 9502 | 0.99 |
| Cerebrovascular accident/ischemic heart disease | Measure LDL cholesterol | 43,032 | 9.17 | 44,196 | 9.04 | 87,228 | 9.1 |
| Treat with antiplatelet drug | 9807 | 2.09 | 10,489 | 2.15 | 20,296 | 2.12 | |
| Heart failure/ischemic heart disease | Treat with beta blocker | 32,810 | 6.99 | 34,312 | 7.02 | 67,122 | 7 |
| Heart failure | Treat with ACEI/ARB | 7189 | 1.53 | 7733 | 1.58 | 14,922 | 1.56 |
| Hepatitis C | Hepatitis B vaccine | 8681 | 1.85 | 8535 | 1.75 | 17,216 | 1.8 |
| Smoking | Encourage smoking cessation | 60,633 | 12.91 | 61,613 | 12.6 | 122,246 | 12.76 |
| Total | 469,514 | 100 | 488,811 | 100 | 958,325 | 100 | |
Abbreviations: ACEI Angiotensin-converting enzyme inhibitor, ARB Angiotensin II receptor blocker, LDL Low-density lipoprotein
Resolution of reminders by type of intervention
| Reminders at baseline | Not resolved | Resolved | % Resolved | Increase (%) | OR (95% CI) | ||
|---|---|---|---|---|---|---|---|
| Control group | 469,514 | 362,542 | 106,972 | 22.8 | 1 (Reference) | ||
| Intervention | 488,811 | 354,397 | 134,414 | 27.5 | 20.6 | 1.29 (1.25–1.34) | <0.001 |
| Pop-up window | 164,006 | 119,972 | 44,034 | 26.8 | 17.5 | 1.24 (1.17–1.30) | <0.001 |
| Above + schedule icon | 154,945 | 111,802 | 43,143 | 27.8 | 21.9 | 1.31 (1.24–1.38) | <0.001 |
| Above + filter settings options | 169,860 | 122,361 | 47,499 | 28.0 | 22.8 | 1.33 (1.27–1.40) | <0.001 |
| Total | 958,325 | 716,939 | 241,386 | 25.2 |
Resolution rates in control and intervention groups by clinical condition and specific reminders
| Resolution (%) | OR (95% CI) | ||||
|---|---|---|---|---|---|
| Clinical condition | Type of reminder | Total | Control group | Intervention group | |
| Type 2 diabetes mellitus | Screen for diabetic retinopathy | 23.88 | 20.05 | 27.52 | 1.51 (1.46–1.57) |
| Measure glycated hemoglobin | 26.23 | 25.32 | 27.11 | 1.1 (1.07–1.13) | |
| Heart failure/ischemic heart disease | Treat with beta blocker | 14.64 | 12.58 | 16.61 | 1.38 (1.32–1.44) |
| Heart failure | Treat with ACEI/ARB | 24.53 | 21.51 | 27.35 | 1.37 (1.27–1.48) |
| High blood pressure | Measure blood pressure | 30.19 | 27 | 33.24 | 1.35 (1.33–1.36) |
| Hepatitis C | Hepatitis B vaccine | 5.59 | 4.99 | 6.2 | 1.26 (1.1–1.43) |
| Atrial fibrillation | Treat with antiplatelet drug/anticoagulant | 31.41 | 28.97 | 33.76 | 1.25 (1.15–1.36) |
| Cerebrovascular accident/ischemic heart disease | Treat with antiplatelet drug | 33.32 | 30.75 | 35.72 | 1.25 (1.18–1.32) |
| Measure LDL cholesterol | 27.19 | 25.71 | 28.63 | 1.16 (1.13–1.19) | |
| Smoking | Encourage smoking cessation | 12.04 | 11.42 | 12.66 | 1.12 (1.09–1.16) |
Abbreviations: ACEI Angiotensin-converting enzyme inhibitor, ARB Angiotensin II receptor blocker, LDL Low-density lipoprotein
Resolution rates by type of reminder in the control and intervention groups
| Resolution (%) | OR (95% CI) | ||
|---|---|---|---|
| Type of reminder | Control group | Intervention group | |
| Screening | 20.05 | 27.52 | 1.51 (1.46–1.57) |
| Measurement | 26.56 | 31.67 | 1.28 (1.27–1.29) |
| Treatment | 18.43 | 23 | 1.32 (1.28–1.36) |
| Vaccination | 4.99 | 6.2 | 1.25 (1.1–1.43) |
| Lifestyle | 11.42 | 12.66 | 1.12 (1.09–1.16) |